DarioHealth Reports Q1 Revenue Decline, Going Concern Warning Amid Continued Cash Burn

summarizeSummary

DarioHealth reported a 17.3% year-over-year revenue decrease and a significant cash burn in Q1 2026, leading management to issue a going concern warning, despite a reduction in net loss.

check_boxKey Events

• Q1 2026 Financial Results

  Revenue for Q1 2026 was $5.584 million, a 17.3% decrease from $6.752 million in Q1 2025. The net loss improved to $8.249 million from $9.227 million in the prior year, resulting in a basic and diluted loss per share of $1.25, down from $2.87.

• Going Concern Warning Issued

  Management expressed 'substantial doubt about the Company's ability to continue as a going concern for twelve months from the date of issuance of these interim condensed consolidated financial statements' due to recurring losses and negative cash flows.

• Cash Position and Burn Rate

  Cash and cash equivalents decreased to $14.977 million as of March 31, 2026, from $21.803 million at December 31, 2025. The company used $6.025 million in operating activities during the first quarter.

• ATM Program Update

  Subsequent to quarter-end, the company sold 7,252 shares under its $20 million At-The-Market (ATM) program for net proceeds of approximately $53,000. $19.946 million remains available under the program.

auto_awesomeAnalysis

DarioHealth's first-quarter results highlight significant financial challenges, with management explicitly stating 'substantial doubt' about the company's ability to continue as a going concern. While the net loss decreased year-over-year, the 17.3% revenue decline and continued cash burn from operations ($6.025 million in Q1) are critical concerns. The company's cash reserves are dwindling, and while a small amount was raised through the ATM program post-quarter, it's insufficient to address the fundamental liquidity issues without further capital raises.